Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2011 3
2012 7
2013 3
2014 5
2015 4
2016 5
2017 3
2018 5
2019 8
2020 4
2021 5
2022 10
2023 4
2024 3
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial.
Pignata S, Scambia G, Katsaros D, Gallo C, Pujade-Lauraine E, De Placido S, Bologna A, Weber B, Raspagliesi F, Panici PB, Cormio G, Sorio R, Cavazzini MG, Ferrandina G, Breda E, Murgia V, Sacco C, Cinieri S, Salutari V, Ricci C, Pisano C, Greggi S, Lauria R, Lorusso D, Marchetti C, Selvaggi L, Signoriello S, Piccirillo MC, Di Maio M, Perrone F; Multicentre Italian Trials in Ovarian cancer (MITO-7); Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens et du sein (GINECO); Mario Negri Gynecologic Oncology (MaNGO); European Network of Gynaecological Oncological Trial Groups (ENGOT-OV-10); Gynecologic Cancer InterGroup (GCIG) Investigators. Pignata S, et al. Among authors: signoriello s. Lancet Oncol. 2014 Apr;15(4):396-405. doi: 10.1016/S1470-2045(14)70049-X. Epub 2014 Feb 28. Lancet Oncol. 2014. PMID: 24582486 Clinical Trial.
No additional benefit of prescribing a very low-protein diet in patients with advanced chronic kidney disease under regular nephrology care: a pragmatic, randomized, controlled trial.
Bellizzi V, Signoriello S, Minutolo R, Di Iorio B, Nazzaro P, Garofalo C, Calella P, Chiodini P, De Nicola L; ERIKA Study Group Investigators of the Italian Society of Nephrology-Conservative Therapy of CKD Work Group. Bellizzi V, et al. Among authors: signoriello s. Am J Clin Nutr. 2022 May 1;115(5):1404-1417. doi: 10.1093/ajcn/nqab417. Am J Clin Nutr. 2022. PMID: 34967847 Free article. Clinical Trial.
Reply to Mocanu CA et al.
Bellizzi V, Signoriello S, Chiodini P, De Nicola L; ERIKA Study Group. Bellizzi V, et al. Among authors: signoriello s. Am J Clin Nutr. 2022 Sep 2;116(3):838-839. doi: 10.1093/ajcn/nqac156. Am J Clin Nutr. 2022. PMID: 35849017 Free article. No abstract available.
Impact of metabolism-related markers on outcomes in ovarian cancer patients: Findings of the MITO16A/MaNGO-OV2 trial.
Indraccolo S, Signoriello S, Piga I, Esposito G, Ferrarini F, Boscolo Bragadin A, Salutari V, Pisano C, Califano D, Bignotti E, Tognon G, Simeon V, Artioli G, Ferrero A, Cinieri S, Bologna A, Chiodini P, Scognamiglio G, Bottoni C, Spina A, Russo D, Arenare L, Perrone F, Pignata S. Indraccolo S, et al. Among authors: signoriello s. Int J Biol Markers. 2024 Dec;39(4):328-337. doi: 10.1177/03936155241296164. Epub 2024 Nov 8. Int J Biol Markers. 2024. PMID: 39513196 Free article.
Circulating fatty acid binding protein 4 (FABP-4) concentrations and mortality in individuals with colorectal cancer in the European Prospective Investigation into Cancer and Nutrition study.
Pham TT, Nimptsch K, Aleksandrova K, Jenab M, Fedirko V, Olsen A, Tjønneland A, Cadeau C, Severi G, Schulze MB, Fortner RT, Katzke V, Agnoli C, Sacerdote C, Tumino R, Signoriello S, Trobajo-Sanmartín C, Gómez JH, Chirlaque MD, Sánchez MJ, Crous-Bou M, May A, Heath A, Aune D, Weiderpass E, Pischon T. Pham TT, et al. Among authors: signoriello s. Int J Cancer. 2025 Aug 26. doi: 10.1002/ijc.70090. Online ahead of print. Int J Cancer. 2025. PMID: 40857027
Prospective evaluation of 92 serum protein biomarkers for early detection of ovarian cancer.
Mukama T, Fortner RT, Katzke V, Hynes LC, Petrera A, Hauck SM, Johnson T, Schulze M, Schiborn C, Rostgaard-Hansen AL, Tjønneland A, Overvad K, Pérez MJS, Crous-Bou M, Chirlaque MD, Amiano P, Ardanaz E, Watts EL, Travis RC, Sacerdote C, Grioni S, Masala G, Signoriello S, Tumino R, Gram IT, Sandanger TM, Sartor H, Lundin E, Idahl A, Heath AK, Dossus L, Weiderpass E, Kaaks R. Mukama T, et al. Among authors: signoriello s. Br J Cancer. 2022 May;126(9):1301-1309. doi: 10.1038/s41416-021-01697-z. Epub 2022 Jan 14. Br J Cancer. 2022. PMID: 35031764 Free PMC article.
65 results